Stockscreener 앱 받기
1.05
9.48%
-0.11
시간 외 거래:
1.07
0.02
+1.90%
Alector Inc 주식(ALEC)의 최신 뉴스
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Alector Sets Stage for Major Healthcare Conference Appearances: BofA and H.C. Wainwright Presentations Coming Up - Stock Titan
Alector, Inc. (NASDAQ:ALEC) Position Raised by Invesco Ltd. - Defense World
Alector Inc (NASDAQ: ALEC) Analysts Expect It Could Climb 71.8% From Current Levels. - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Alector Inc (ALEC) shows promising results - uspostnews.com
Alector Inc [ALEC] Shares Fall Approximately -76.81% Over the Year - knoxdaily.com
Market Highlights: Alector Inc (ALEC) Ends on a High Note at 1.22 - DWinneX
Alector Inc (ALEC) Stock: A Comprehensive 52-Week Review - investchronicle.com
XTX Topco Ltd Acquires 22,381 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Geode Capital Management LLC Boosts Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector Inc (ALEC): A Sitting Duck With -250.88% Upside Potential - Stocksregister
Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners - simplywall.st
There is no way Alector Inc (ALEC) can keep these numbers up - Sete News
A Guide To The Risks Of Investing In Alector Inc (ALEC) - knoxdaily.com
ALEC’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Neogenomics Inc (NEO) Stock’s Detailed Analysis - Marketing Sentinel
Alector Inc (ALEC): What Makes The Stock Good? - Marketing Sentinel
Gentherm Inc Is A Buy Small Cap Stock: Analysts - Marketing Sentinel
Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co. - Defense World
Alector concludes enrolment in Phase II trial of Alzheimer’s treatment - Yahoo Finance
What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - Stocksregister
Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - marketscreener.com
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease - GlobeNewswire
Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | - GuruFocus
Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan
Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa
Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com
Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com
Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter
Alector Announces Resignation of Chief Medical Officer - TipRanks
Alector Appoints New Chief Medical Officer - MarketScreener
Alector Provides Executive Leadership Update - The Manila Times
Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace
Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st
Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha
Mizuho’s latest rating for ALEC stock - Knox Daily
Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India
Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia
Alector announces workforce reduction to cut costs - Investing.com
Alector to Cut 13% of Workforce - MarketWatch
Have Alector Insiders Been Selling Stock? - simplywall.st
5.24%
자본화:
|
볼륨(24시간):